Inhibitor of HIV-1 reverse transcriptase:: N′-(5-bromo-2-pyridyl)-N-[2-(2,5-di-methoxyphenyl)ethyl] thiourea

被引:22
|
作者
Sudbeck, EA
Jennissen, JD
Venkatachalam, TK
Ucukun, FM
机构
[1] Hughes Inst, Dept Biol Struct, Drug Discovery Program, St Paul, MN USA
[2] Hughes Inst, Dept Chem, Drug Discovery Program, St Paul, MN USA
[3] Hughes Inst, Dept Virol, Drug Discovery Program, St Paul, MN USA
关键词
D O I
10.1107/S0108270199012044
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The crystal structure of the title compound, C16H18BrN3O2S (HI-236), a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase, revealed an intramolecular hydrogen bond between a thiourea N atom and the pyridyl-N atom [N-H ... N = 2.671(3) Angstrom, graph-set motif S-1(1)(6)] that imparts a more rigid conformation to the molecule. A second hydrogen bond between a thiourea N atom and the thiocarbonyl-S atom [N-H-2... S = 3.403(2) Angstrom, graph-set motif R-2(2)(8)] was observed between inversion-related molecules of HI-236. The first-level hydrogen-bond graph-set notation for HI-236 was determined to be St(6)R-2(2)(8).
引用
收藏
页码:2122 / 2124
页数:3
相关论文
共 50 条
  • [21] N-(2-(2-pyridyl)ethyl)chitosan: Synthesis, characterization and sorption properties
    Bratskaya, S. Yu.
    Azarova, Yu. A.
    Matochkina, E. G.
    Kodess, M. I.
    Yatluk, Yu. G.
    Pestov, A. V.
    CARBOHYDRATE POLYMERS, 2012, 87 (01) : 869 - 875
  • [22] In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)
    Uckun, Fatih M.
    Tibbles, Heather
    Erbeck, Douglas
    Venkatachalam, Taracad K.
    Qazi, Sanjive
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (04): : 218 - 226
  • [23] PALLADIUM(II) COMPLEXES OF N-(2-PYRIDYLMETHYL)-2-PYRIDYLACETAMIDE AND N-[2-(2-PYRIDYL)ETHYL]-2-PYRIDINECARBOXAMIDE
    NONOYAMA, M
    YAMASAKI, K
    NIPPON KAGAKU KAISHI, 1973, (10) : 1893 - 1895
  • [24] N-[(R)-(6-Bromo-2-methoxyquinolin-3-yl)(phenyl)methyl]-N-[(S)-1-(4-methoxyphenyl)ethyl]-2-(piperazin-1-yl)acetamide
    Yuan, Lei
    Wang, Rui
    Li, Chang-Yi
    Wang, Zhi-Qiang
    Sun, Tie-Min
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2921 - U365
  • [25] 2-(1-Ethyl-5-methoxy-1H-indol-3-yl)-N-(4-methoxyphenyl)-2-oxoacetamide
    Chen, Li-Ting
    Lu, Yan-Ling
    Chen, Hong
    Zhou, Jing
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O358 - U546
  • [26] N-[2-(GLYCOSYLOXY)ETHYL]CHITOSAN DERIVATIVES .1. PREPARATION AND CHARACTERIZATION OF N-[2-(GLYCOSYLOXY)ETHYL]CHITOSAN DERIVATIVES
    HOLME, KR
    HALL, LD
    CARBOHYDRATE RESEARCH, 1992, 225 (02) : 291 - 306
  • [27] N-(5-Chloro-3-methyl-1-phenylpyrazol-4-ylcarbonyl)-N′-(2-methoxyphenyl)thiourea
    Du, Hai-tang
    Du, Hai-jun
    Lu, Ming
    Sun, Li-li
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O609 - U1304
  • [28] HIV-1 REVERSE-TRANSCRIPTASE - INHIBITION BY 2',5'-OLIGOADENYLATES
    SOBOL, RW
    FISHER, WL
    REICHENBACH, NL
    KUMAR, A
    BEARD, WA
    WILSON, SH
    CHARUBALA, R
    PFLEIDERER, W
    SUHADOLNIK, RJ
    BIOCHEMISTRY, 1993, 32 (45) : 12112 - 12118
  • [29] N-[2-(4-methylphenyl)ethyl]-N′-[2-(5-bromopyridyl)]-thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1
    Uckun, FM
    Mao, C
    Pendergrass, S
    Maher, D
    Zhu, D
    Tuel-Ahlgren, L
    Venkatachalam, TK
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2000, 11 (02): : 135 - 140
  • [30] (E)-2-(4-Methoxyphenyl)-N-(2-pyridyl)-3-(2-pyridylamino)acrylamide
    Xiao, Zhu-Ping
    Peng, Xiao-Chun
    Wang, Ying-Chun
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O672 - U1293